423
Views
28
CrossRef citations to date
0
Altmetric
Original Articles

Four new triterpenoids from the leaves of Psidium guajava

, , , , , & show all
Pages 348-354 | Received 25 Jul 2011, Accepted 27 Dec 2011, Published online: 01 Mar 2012
 

Abstract

Four new triterpenoids, psiguanins A–D (14), along with 13 known ones (517), were isolated from the leaves of Psidium guajava. The structures of new compounds were determined as 2α,3β-dihydroxy-taraxer-20-en-28-oic acid (1), 2α,3β,12α,13β-tetrahydroxy-urs-28-oic acid (2), 2α,3β,12β,13β-tetrahydroxy-urs-28-oic acid (3), and 2α,3β,12β,13α-tetrahydroxy-urs-28-oic acid (4), respectively, on the basis of comprehensive spectroscopic methods and molecular modeling calculation. Among them, compound 4 was characterized as an unusual ursane-type triterpenoid with cis-fused C/D ring system.

Acknowledgements

Financial support of this research was provided by the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT0965), the National Natural Science Foundation of China (No. 81172946), the Research Team Program of Natural Science Foundation of Guangdong Province (No. 8351063201000003), the Science and Technology Development Fund of Macao Special Administrative Region (No. 013/2008/A1), and the Fundamental Research Funds for the Central Universities (No. 21611405).

Notes

1. These authors contributed equally to this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.